Literature DB >> 14997936

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

R Höftberger1, F Aboul-Enein, W Brueck, C Lucchinetti, M Rodriguez, M Schmidbauer, K Jellinger, H Lassmann.   

Abstract

Multiple sclerosis is considered to be an immune-mediated disease of the central nervous system, characterized by chronic inflammation, primary demyelination and axonal damage. The mechanisms of demyelination and axonal injury are heterogeneous and complex. One possible mechanism is direct damage of oligodendrocytes and neurons by Class I MHC restricted cytotoxic T-cells. In this study we analyzed the expression of functional MHC class I molecule complex, consisting of alpha-chain and beta2-microglobulin, in a large sample of human autopsy material, containing 10 cases of acute MS, 10 cases of chronic active MS, 10 cases of chronic inactive MS and 21 controls. To examine the expression of MHC class I and II molecules on the different cell-types in brain, we used quantitative immunohistochemical techniques, double staining and confocal laser microscopy scans on paraffin embedded sections. We found constitutive expression of MHC class I molecule on microglia and endothelial cells. A hierarchical up-regulation of MHC class I was present on astrocytes, oligodendrocytes, neurons and axons, depending upon the severity of the disease and the activity of the lesions. MHC class II molecules were expressed on microglia and macrophages, but not on astrocytes. These data indicate that in MS lesions all cells of the central nervous system are potential targets for Class I MHC restricted cytotoxic T-cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997936     DOI: 10.1111/j.1750-3639.2004.tb00496.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  68 in total

1.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

4.  Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Dusan Stefoski; Roumen Balabanov
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-23       Impact factor: 4.147

Review 5.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

6.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

Review 7.  Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them.

Authors:  Erin J Adams
Journal:  Curr Opin Immunol       Date:  2013-10-11       Impact factor: 7.486

8.  A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection.

Authors:  Jeremiah McDole; Georgette Suidan; Erin Boespflug; Jie Cheng; Yi Chen; Istvan Pirko; Aaron Johnson
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

Review 9.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.